” Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. ”
Read New drugs trail many old ones in effectiveness against disease
by Sharon Begley, June 3, 2013, Reuters